Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.
Mark L LevyJanwillem W H KocksSinthia Z Bosnic-AnticevichGuilherme SafiotiMichael ReichMichael DePietroMario CastroNabeel FarooquiNjira L LugogoRandall BrownTanisha HillThomas LiHenry ChrystynPublished in: NPJ primary care respiratory medicine (2024)
Electronic inhalers provide information about patterns of routine inhaler use. During a 12-week study, 360 asthma patients using albuterol Digihaler generated 53,083 inhaler events that were retrospectively analyzed. A total of 41,528 (78%) of the recorded inhalation events were suitable for flow analysis (having a PIF ≥ 18 L/min and <120 L/min). Median PIF, inhalation volume, inhalation duration, and time to PIF for these events steadily decreased between the first and last 10 days of the study, by 5.1%, 12.6%, 15.9%, and 6.4%, respectively. Continuous short-acting beta 2 -agonist (SABA) overuse, defined as ≥2 SABA inhalations/week throughout the study period, was seen in 29% (n = 104) of patients. Of 260 patients with ≥1 instance of acute short-term SABA overuse, 55 (21%) had a confirmed exacerbation. Electronic recording of real-life inhaler use can capture valuable, objective information that could inform disease management and clinical decision-making.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic obstructive pulmonary disease
- chronic kidney disease
- newly diagnosed
- decision making
- peritoneal dialysis
- randomized controlled trial
- healthcare
- prognostic factors
- hepatitis b virus
- cystic fibrosis
- lung function
- patient reported outcomes
- patient reported
- allergic rhinitis
- data analysis
- aortic dissection
- mechanical ventilation